This distinct pattern of MLH1/PMS2 double loss matches the IHC pattern associated with MLH1 abrogation in human CRCs and allows a distinctive delineation of cancer cell clusters and adjacent healthy cells [40, 41]. This evidence concerns the gene PMS2 and cancer.